about
An optical imaging method to monitor stem cell migration in a model of immune-mediated arthritis.Indocyanine green-enhanced imaging of antigen-induced arthritis with an integrated optical imaging/radiography system.The influence of ferucarbotran on the chondrogenesis of human mesenchymal stem cells.Labeling human mesenchymal stem cells with fluorescent contrast agents: the biological impactMR imaging features of gadofluorine-labeled matrix-associated stem cell implants in cartilage defects.Breast cancer subtype intertumor heterogeneity: MRI-based features predict results of a genomic assay.Long-term outcome and toxicities of intraoperative radiotherapy for high-risk neuroblastoma.Cell tracking with optical imaging.Decreased aortic growth and middle aortic syndrome in patients with neuroblastoma after radiation therapy.Labeling stem cells with fluorescent dyes for non-invasive detection with optical imagingRelaxation effects of ferucarbotran-labeled mesenchymal stem cells at 1.5T and 3T: discrimination of viable from lysed cells.Detection of postoperative granulation tissue with an ICG-enhanced integrated OI-/X-ray System.Imaging characteristics of DHOG, a hepatobiliary contrast agent for preclinical microCT in mice.Improved fluorescence of indocyanine green in vitro and in vivo after simple cooling procedures.Background, current role, and potential applications of radiogenomics.Apparent diffusion coefficient in estrogen receptor-positive and lymph node-negative invasive breast cancers at 3.0T DW-MRI: A potential predictor for an oncotype Dx test recurrence score.Tissue harmonic imaging, frequency compound imaging, and conventional imaging: use and benefit in breast sonographyIncidence of benign and malignant peri-implant fluid collections and masses on magnetic resonance imaging in women with silicone implantsDifferentiation between subcentimeter carcinomas and benign lesions using kinetic parameters derived from ultrafast dynamic contrast-enhanced breast MRIA machine learning model that classifies breast cancer pathologic complete response on MRI post-neoadjuvant chemotherapyUltrafast dynamic contrast-enhanced breast MRI may generate prognostic imaging markers of breast cancer
P50
Q33924632-70E75A03-533B-4C7F-A6D3-740EDD52EC3CQ34063437-66BC1FE4-397A-4417-805A-25DC84253684Q34105714-BAE1F443-3350-4DBE-B7FC-94264147FC7DQ34501019-33154B00-9772-4329-BAD1-08E6BFAEC57BQ34515707-97F839B8-C4EB-4C9D-B5C6-CCDDD9447C4EQ36668293-D53C2F42-92CB-4FA7-9B29-6DE2E4771192Q36828391-D58B0199-0D09-4A40-9C1F-BBE2A0CE2F6FQ37174473-C08B64AA-85D3-40BE-A1AB-1A57504243CAQ37395959-35CA1326-74F3-4DB3-AE54-E351D4469423Q41837062-ECC1DE86-8AC5-4067-89A6-477594CEE640Q42057539-35F8A90B-6423-49B4-8D53-059ABB31491DQ43213677-0A065EBA-BAEA-403A-A9DC-345EBA52E9F5Q45976031-06D07FD5-D722-417F-B57E-618A0815763DQ46052104-8F0B12E0-4E6C-4560-AF6D-F7AE8C60273AQ47669653-06B0DFBE-3155-497C-9E44-6D67764549A0Q48236804-E124F758-DAEA-4597-8DBE-5A6F5799BDA7Q80656161-5E76419B-58C3-4E59-86D5-63ECD4C39B98Q90376768-D996DA6C-86F6-4E90-9387-0FE2B6D9DDEAQ93001920-E572B14D-4735-4F86-B33F-75405C807618Q95933291-506841C2-90AE-4D00-B9B6-154874688ABCQ95933407-68238D4D-9971-4564-B131-F34CC7895723
P50
description
researcher ORCID ID = 0000-0002-1407-7012
@en
wetenschapper
@nl
name
Elizabeth J Sutton
@ast
Elizabeth J Sutton
@en
Elizabeth J Sutton
@es
Elizabeth J Sutton
@nl
type
label
Elizabeth J Sutton
@ast
Elizabeth J Sutton
@en
Elizabeth J Sutton
@es
Elizabeth J Sutton
@nl
prefLabel
Elizabeth J Sutton
@ast
Elizabeth J Sutton
@en
Elizabeth J Sutton
@es
Elizabeth J Sutton
@nl
P106
P21
P31
P496
0000-0002-1407-7012